Log in to search using one of your social media accounts:


Hormone replacement therapy reduces risk of early death

Women who use hormone replacement therapy have significantly decreased risk of heart attack or stroke, according to a study being presented at the American College of Cardiology’s 66th Annual Scientific Session& Expo on 17 March.Telegraph
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

Authors: Suzuki E, Fujita D, Takahashi M, Oba S, Nishimatsu H Abstract Mesenchymal stem cells (MSCs) are multipotent stem cells that reside in various organs. They have the capacity to differentiate into various cell types, including cardiomyocytes, vascular endothelial cells, and vascular smooth muscle cells. Among the various MSCs, bone marrow-derived MSCs (BMMSCs) have been widely used for treating acute myocardial infarction (AMI) and ischemic heart failure (IHF) in preclinical and clinical studies. Although the beneficial effects of BMMSCs in treating AMI and IHF were originally attributed to their capacity to...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Abstract Cardiovascular disease is the main cause of death worldwide, and is principally caused by atherosclerosis, with subsequent thrombus formation, eventually provoking an acute myocardial infarction or a stroke. The formation and progression of the atherosclerotic plaques responds to multiple factors including certain diets. Intensive research has elucidated the role of diet in cardiovascular disease and has led to public health policies focusing on educating the population on the role of nutrition in cardiovascular health. Compelling evidence shows that a healthy diet, rich in fruit and vegetables with moder...
Source: Atherosclerosis - Category: Cardiology Authors: Tags: Front Biosci (Landmark Ed) Source Type: research
Conclusions The effect of more potent P2Y12 inhibitors compared to clopidogrel on efficacy and safety endpoints is consistent in elderly and younger patients. These data imply that potent P2Y12 inhibitors should not be withheld from eligible patients solely because of advanced age.
Source: American Heart Journal - Category: Cardiology Source Type: research
We examined whether different amounts and types of physical activity are associated with lower mortality and CVD in countries at different economic levels. Methods In this prospective cohort study, we recruited participants from 17 countries (Canada, Sweden, United Arab Emirates, Argentina, Brazil, Chile, Poland, Turkey, Malaysia, South Africa, China, Colombia, Iran, Bangladesh, India, Pakistan, and Zimbabwe). Within each country, urban and rural areas in and around selected cities and towns were identified to reflect the geographical diversity. Within these communities, we invited individuals aged between 35 and 70 years ...
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: Available online 21 September 2017 Source:Pathophysiology Author(s): D. Neil Granger, Peter R. Kvietys Microvascular dysfunction is well established as an early and rate-determining factor in the injury response of tissues to ischemia and reperfusion (I/R). Severe endothelial cell dysfunction, which can develop without obvious morphological cell injury, is a major underlying cause of the microvascular abnormalities that accompany I/R. While I/R-induced microvascular dysfunction is manifested in different ways, two responses that have received much attention in both the experimental and clinical setting a...
Source: Pathophysiology - Category: Pathology Source Type: research
Conclusions Over the last two decades Polish urban stroke units may have achieved a significant reduction of the occurrence of some noninfectious complications (i.e. MI, exacerbated CHF and DVT). However, the list of conditions associated with stroke unit mortality includes not only MI and exacerbated CHF but also PE, gastrointestinal bleeding and recurrent stroke.
Source: Polish Journal of Neurology and Neurosurgery - Category: Neurosurgery Source Type: research
Scientists are still trying to determine the health effects of e-cigarettes, and until now, they have focused their attention on the addictive properties of nicotine and the potentially cancer-causing agents in the vapors the devices emit. But in a small new study published in the Journal of the American Heart Association, researchers document another growing health concern of e-cigs: that they may have negative effects on the heart. Scientists led by Dr. Holly Middlekauff, professor of medicine at University of California Los Angeles, and her colleagues found that devices that contain nicotine can boost adrenaline levels ...
Source: TIME.com: Top Science and Health Stories - Category: Consumer Health News Authors: Tags: Uncategorized are e cigs bad for your heart are e cigs safe e-cig e-cigarette E-Cigarettes e-cigs e-cigs and heart ecig Heart Disease how to quit smoking Nicotine smoking and heart health smoking cessation tobacco what is nic Source Type: news
ConclusionsOn-pump is associated with a decreased risk of additional revascularization by 1  year. However, this appears to be a cost of longer hospitalization.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
CONCLUSION: these results support the use of evolocumab as add-on therapy to statins for high cardiac-risk patients not achieving optimal goals of LDL-C. Longer-term studies are needed to further clarify the efficacy and safety of evolocumab. PMID: 28925859 [PubMed - as supplied by publisher]
Source: Current Cardiology Reviews - Category: Cardiology Tags: Curr Cardiol Rev Source Type: research
More News: Cardiology | Endocrinology | Heart | Heart Attack | Hormone Replacement Therapy | Hormones | Stroke | Study | Women